Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Net Margin Growth (5y) (2017 - 2026)

Analysis

Iqvia Holdings (IQV) Net Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.00
Mar 31, 2026 23.00
Dec 31, 2025 698.00
Sep 30, 2025 433.00
Jun 30, 2025 744.00
Mar 31, 2025 376.00
Dec 31, 2024 995.00
Sep 30, 2024 476.00
Jun 30, 2024 691.00
Mar 31, 2024 525.00
Dec 31, 2023 953.00
Sep 30, 2023 547.00
Jun 30, 2023 539.00
Mar 31, 2023 539.00
Dec 31, 2022 -3,486.00
Sep 30, 2022 453.00
Jun 30, 2022 463.00
Mar 31, 2022 486.00
Dec 31, 2021 1,968.00
Sep 30, 2021 -146.00